To explore whether the observations of an increased risk for plaque formation seen in mice may also correlate with cardiac risk in human samples, we measured fresh human plasma LL37/ hCAP18 levels in patients with atherosclerosis. This evidence concerns the gene CAMP and atherosclerosis.